Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,500
Closed -$640K 10701
2025
Q2
$640K Buy
+6,500
New +$615K ﹤0.01% 6485
2023
Q4
Sell
-5,300
Closed -$495K 9136
2023
Q3
$495K Sell
5,300
-25,400
-83% -$2.35M ﹤0.01% 6321
2023
Q2
$2.81M Buy
30,700
+26,200
+582% +$2.15M ﹤0.01% 3618
2023
Q1
$331K Sell
4,500
-2,700
-38% -$234K ﹤0.01% 7029
2022
Q4
$601K Sell
7,200
-16,400
-69% -$1.48M ﹤0.01% 5816
2022
Q3
$2.28M Buy
23,600
+12,000
+103% +$1.43M ﹤0.01% 3966
2022
Q2
$1.22M Sell
11,600
-48,500
-81% -$6.2M ﹤0.01% 5107
2022
Q1
$10.4M Buy
60,100
+32,500
+118% +$4.86M ﹤0.01% 1947
2021
Q4
$4.47M Buy
27,600
+25,800
+1,433% +$4.15M ﹤0.01% 3037
2021
Q3
$268K Sell
1,800
-39,300
-96% -$8.17M ﹤0.01% 8398
2021
Q2
$10.1M Buy
41,100
+38,600
+1,544% +$10.1M ﹤0.01% 1697
2021
Q1
$662K Sell
2,500
-9,200
-79% -$2.59M ﹤0.01% 6266
2020
Q4
$3.43M Sell
11,700
-44,800
-79% -$11.5M ﹤0.01% 2626
2020
Q3
$13.4M Buy
56,500
+21,500
+61% +$4.89M 0.01% 1011
2020
Q2
$6.95M Buy
35,000
+23,200
+197% +$4.33M 0.01% 1493
2020
Q1
$2.17M Buy
+11,800
New +$2.1M ﹤0.01% 1943
2019
Q2
Sell
-2,000
Closed -$247K 5088
2019
Q1
$247K Buy
+2,000
New +$251K ﹤0.01% 4452
2017
Q1
Sell
-20,000
Closed -$853K 4082
2016
Q4
$853K Buy
+20,000
New +$850K ﹤0.01% 2251

Other funds holding AMED

Jane Street's AMED Position: Q3 2025 in Review

Jane Street sold out of Amedisys (AMED) in Q3 2025, closing a stake of 48,371 shares — an estimated $4.76M sold.

Jane Street first reported a position in AMED in Q2 2014 and held it in 26 quarters. The position peaked at $15.5M in Q2 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Jane Street reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Jane Street sold 48,371 Amedisys shares in Q3 2025, an estimated $4.76M.
  • Jane Street first reported a position in Amedisys in Q2 2014 and held it in 26 quarters.
  • Jane Street's Amedisys position peaked at $15.5M in Q2 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.